Award-winning global leader in digital patient recruitment GeoMap Clinical by TrialWire announced today new tools added to the GeoMap geo-targeting Platform that can restore and boost patient recruitment numbers at a time when people are avoiding clinic appointments for fear of COVID-19.
|
|
The GeoMap Platform is currently recruiting for clinical trials in North America, Latin America, Australia, New Zealand, Asia and the EU.
The company said:
“Most studies require at least 1 clinic visit for check-ups, monitoring and tests, but many sponsors, investigators and study coordinators are finding that potential patients are staying away because of fear of contracting the virus in a clinic.
Increasingly people are also not traveling unless they really need to – especially people with underlying conditions, which is much of the potential clinical trial patient community.”
The GeoMap Platform has introduced a range of new tools to recruit patients as part of the GeoMap process which includes online screening using the Proprietary AI Patient Screener Funnel of more than 300+ possible questions, and direct secure encrypted contact with the study coordinator for a phone call.
The Platform is the fastest most accurate targeting tool available that doesn’t require IRB/EC approval and can start recruiting in under 24 hours.
The Platform had strict verification and email encryption so PHI is managed in accordance with state and country regulatory guidelines.
For a full briefing on the new recruitment support tools on the GeoMap Clinical Platform, please click here:
https://www.geomap-clinicaltrialfinder.com/patient-recruitment-covid-19/
.jpg){kind=tracking}
